Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects
- PMID: 17963768
- DOI: 10.1016/j.ijgo.2007.09.004
Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects
Abstract
Misoprostol, a synthetic prostaglandin E1 analogue, is commonly used for medical abortion, cervical priming, the management of miscarriage, induction of labor and the management of postpartum hemorrhage. It can be given orally, vaginally, sublingually, buccally or rectally. Studies of misoprostol's pharmacokinetics and effects on uterine activity have demonstrated the properties of the drug after various routes of administration. These studies can help to discover the optimal dose and route of administration of misoprostol for individual clinical applications. Misoprostol is a safe drug but serious complications and teratogenicity can occur with unsupervised use.
Similar articles
-
Misoprostol and pregnancy.N Engl J Med. 2001 Jan 4;344(1):38-47. doi: 10.1056/NEJM200101043440107. N Engl J Med. 2001. PMID: 11136959 Review. No abstract available.
-
[Pharmacology of misoprostol (pharmacokinetic data, adverse effects and teratogenic effects)].J Gynecol Obstet Biol Reprod (Paris). 2014 Feb;43(2):114-22. doi: 10.1016/j.jgyn.2013.11.006. Epub 2014 Jan 17. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 24440131 French.
-
Misoprostol to treat postpartum haemorrhage: a systematic review.BJOG. 2005 May;112(5):547-53. doi: 10.1111/j.1471-0528.2004.00512.x. BJOG. 2005. PMID: 15842275 No abstract available.
-
The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.Contraception. 2006 Jul;74(1):26-30. doi: 10.1016/j.contraception.2006.03.005. Epub 2006 Apr 27. Contraception. 2006. PMID: 16781256 Review.
-
A benefit-risk assessment of misoprostol for cervical ripening and labour induction.Drug Saf. 2002;25(9):665-76. doi: 10.2165/00002018-200225090-00005. Drug Saf. 2002. PMID: 12137560 Review.
Cited by
-
Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone.Am J Obstet Gynecol MFM. 2023 Feb;5(2S):100731. doi: 10.1016/j.ajogmf.2022.100731. Epub 2022 Aug 24. Am J Obstet Gynecol MFM. 2023. PMID: 36028160 Free PMC article. Review.
-
Evaluation of isosorbide-5-mononitrate as a cervical ripening agent prior to induced abortion in contrast to misoprostol- a randomized controlled trial.Obstet Gynecol Sci. 2019 Sep;62(5):313-321. doi: 10.5468/ogs.2019.62.5.313. Epub 2019 Aug 9. Obstet Gynecol Sci. 2019. PMID: 31538074 Free PMC article.
-
Postpartum Vaginal Blood Loss following Two Different Methods of Cervical Ripening.Obstet Gynecol Int. 2017;2017:1678265. doi: 10.1155/2017/1678265. Epub 2017 Dec 19. Obstet Gynecol Int. 2017. PMID: 29410681 Free PMC article.
-
Simplifying oral misoprostol protocols for the induction of labour.BJOG. 2017 Oct;124(11):1642-1645. doi: 10.1111/1471-0528.14657. Epub 2017 May 15. BJOG. 2017. PMID: 28342186 Free PMC article. No abstract available.
-
Outcome of misoprostol and oxytocin in induction of labour.SAGE Open Med. 2017 Mar 23;5:2050312117700809. doi: 10.1177/2050312117700809. eCollection 2017. SAGE Open Med. 2017. PMID: 28540049 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical